Zobrazeno 1 - 10
of 238
pro vyhledávání: ''
Publikováno v:
Drug Design, Development and Therapy
Human epidermal growth factor receptor 2 (HER2) positive cancers account for 15–20% of all breast tumors. Several drugs have been approved in the metastatic setting, including monoclonal antibodies, tyrosine kinase inhibitors (TKI) and, more recent
Publikováno v:
Drug Design, Development and Therapy
Ping Li,1,2 Yanli Chen,1 Luxiang Luo,1 Huiwen Yang,1 Yufang Pan1 1School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, People’s Republic of China; 2Department of Pharmacy, Xiamen Children’s Hospital, Children’s Hospital o
Publikováno v:
Drug Design, Development and Therapy
Lung cancer remains the most common cancer worldwide. Although significant advances in screening have been made and early diagnosis strategies and therapeutic regimens have been developed, the overall survival rate remains bleak. Curcumin is extracte
Publikováno v:
Drug Design, Development and Therapy
Neovascular age-related macular degeneration (nAMD) treatment has been revolutionized by the introduction of vascular endothelial growth factor antagonists (anti-VEGF), but the need for frequent intravitreal injections poses a heavy burden to patient
Publikováno v:
Drug Design, Development and Therapy
Tingting Sun, 1,* Qingquan Wei, 1,* Peng Gao, 1,* Yongjie Zhang, 2 Qing Peng 1 1Department of Ophthalmology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, 200072, People’s Republic of China; 2Department of Human Anatomy, Nanjing
Publikováno v:
Drug Design, Development and Therapy
Attention-deficit/hyperactivity disorder (ADHD) is characterized by age-inappropriate and impairing levels of inattention, hyperactivity, or impulsivity, or a combination of these characteristics. It is estimated to affect around 4% of adults worldwi
Autor:
Sadia Sarwar, Amani Alghamdi, Jun Qing Yu, Abir Abdullah Alamro, Fazlul Huq, Komal Naeem, Muazzam Arif, Salamat Ullah
Publikováno v:
Drug Design, Development and Therapy
Sadia Sarwar,1,2 Abir A Alamro,3 Amani A Alghamdi,3 Komal Naeem,4 Salamat Ullah,5 Muazzam Arif,6 Jun Qing Yu,1 Fazlul Huq7 1Discipline of Biomedical Sciences, Sydney Medical School, The University of Sydney, Cumberland Campus, Sydney, NSW, Australia;
Autor:
Mauricio Tohen
Publikováno v:
Drug Design, Development and Therapy
Depressive episodes, the most frequent episodes in bipolar disorder, contribute in large part to poor functional outcomes. Very few treatments, however, have been approved by the Food and Drug Administration for the treatment of bipolar depression. C
Autor:
Ting Shen, Zijian Yang
Publikováno v:
Drug Design, Development and Therapy
Ting Shen, Zijian Yang Department of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaCorrespondence: Zijian YangDepartment of Ophthalmology, Ruijin Hospital Affiliated Medi
Autor:
Adriana Balduzzi, Gerald A. Soff, James B. Bussel, Tatiana Lawrence, Nichola Cooper, John W. Semple
Publikováno v:
Drug Design, Development and Therapy
Thrombocytopenia results from a variety of conditions, including radiation, chemotherapy, autoimmune disease, bone marrow disorders, pathologic conditions associated with surgical procedures, hematopoietic stem cell transplant (HSCT), and hematologic